TriSalus Life Sciences (TLSI) Free Cash Flow (QoQ) (2021 - 2026)
TriSalus Life Sciences (TLSI) Free Cash Flow (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.15 Bn | 176.85 Bn | 6.27 Bn |
| 2 | Stryker | 128.85 Bn | 125.98 Bn | 3.81 Bn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.66 Bn | 67.21 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.18 Bn | 2.07 Bn |
| 10 | TriSalus Life Sciences | 224.20 Mn | 167.64 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -295.28% |
| Dec 31, 2025 | 63.32% |
| Sep 30, 2025 | 37.05% |
| Jun 30, 2025 | -58.16% |
| Mar 31, 2025 | 15.26% |
| Dec 31, 2024 | 50.87% |
| Sep 30, 2024 | 18.29% |
| Jun 30, 2024 | -23.31% |
| Mar 31, 2024 | -14.49% |
| Dec 31, 2023 | 56.28% |
| Sep 30, 2023 | -135.67% |
| Jun 30, 2023 | 11.83% |
| Mar 31, 2023 | -33.53% |
| Dec 31, 2022 | 65.60% |
| Sep 30, 2022 | -3,183.87% |
| Jun 30, 2022 | -63.57% |
| Mar 31, 2022 | 37.44% |
| Dec 31, 2021 | -86.48% |
| Sep 30, 2021 | 24.90% |
| Jun 30, 2021 | -136.20% |